In the management of a patient presenting with acute liver failure it is essential to identify both the cause and the type of liver failure (Table I) . Patients may have established chronic liver disease and develop liver failure during intercurrent infections or variceal haemorrhage, or they may have no previous history of liver disease. With the latter group the presentation-is then either as fulminant liver failure (encephalopathy within 8 weeks of onset of symptoms) or with a slower course (encephalopathy developing within 6 months of onset) which has been termed late-onset hepatic failure. The measures discussed in this paper apply only to those with no antecedent history of liver disease in whom regeneration of the liver to a normal structure is seen in the survivors. Paradoxically in fulminant hepatic failure (FHF) the prognosis is better the more rapid the onset of encephalopathy, as measured from the first appearance of jaundice. that patients were treated by liver support did not seem to affect outcome. In that time, the underlying aetiology of the liver failure had the greatest influence on prognosis many more of the patients with paracetamol poisoning or hepatitis A or B survived than did.those with non-A, non-B hepatitis or drug-induced liver failure (Table III) . Similarly, the frequency with which the various complications can be combatted by intensive care management also differs in the various aetiological sub-groups, presumably reflecting the varying ability of the liver to regenerate. With respect to the latter, Japanese workers have used glucagon and insulin to stimulate liver regeneration in acute viral hepatitis but its value in improving survival in fulminant hepatic failure is unproven. A study of this is in progress at King's College Hospital using serum a-fetoprotein as a measure of hepatic regeneration.
In patients with a poor intrinsic prognosis, e.g. non-A, non-B hepatitis, halothane hepatitis or drug idiosyncrasy (Figure 3) , liver transplantation should be considered early in the course in order that as much time is given for a donor organ to become available. In a recent series of such cases in the Cambridge/King's College Hospital joint programme, 65% of patients survived and are doing well following transplantation. Many of the anticipated difficulties relating to severe coagulation disturbance and presence of cerebral oedema at the time of operation did not materialize. In the non-A, non-B fulminant hepatitis group there may be a mild recurrence of the original infection at 6 weeks to 3 months after the transplant.
Summary
The principles of management for acute liver failure are: 1. Accurate diagnosis of the type -fulminant, late onset, acute on chronic-and establishment of likely aetiology. 2. Early detection and treatment of complications, particularly metabolic acidosis (early), renal failure, cerebral oedema and infections (late). 3. Optimization of conditions for regeneration by maintenance of normal metabolic milieu (? removal of toxins). 4. Early consideration of an orthotopic liver transplant for poor prognosis group.
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